November 2020 - DTx Pharma

DTx Pharma to Present at Several Upcoming Virtual Events

Michael Jaramillo2021-01-29T08:35:53-08:00November 24th, 2020|

SAN DIEGO, Nov. 25, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers [...]

DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer

Michael Jaramillo2021-01-29T08:37:53-08:00November 9th, 2020|

PR Newswire, San Diego – November 9, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the [...]